comparemela.com

ProfoundBio Receives FDA Study May Proceed Letter for PRO1184, a Folate Receptor Alpha-Directed ADC with a Topoisomerase 1 Inhibitor Payload, and Welcomes Naomi Hunder, M.D., as Chief Medical Officer

ProfoundBio Receives FDA "Study May Proceed" Letter for PRO1184, a Folate Receptor Alpha-Directed ADC with a Topoisomerase 1 Inhibitor Payload, and Welcomes Naomi Hunder, M.D., as Chief Medical Officer

prnasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnasia.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

China ,Suzhou ,Jiangsu ,Baiteng Zhao ,Prnewswire Profoundbio ,Naomi Hunder ,Affairs At Acerta Pharma ,University Of Pennsylvania ,Drug Administration ,Carleton College ,Jefferson Medical College ,Clinical Development At Seattle Genetics ,Clinical Development ,Chief Medical ,Chief Executive ,Chief Medical Officer ,Silverback Therapeutics ,Vice President ,Medical Affairs ,Acerta Pharma ,Seattle Genetics ,Internal Medicine ,Fred Hutchinson Cancer Research ,

comparemela.com © 2020. All Rights Reserved.